Suboptimal care for chronic pancreatitis patients revealed by moderate to low adherence to the United European Gastroenterology evidence-based guidelines (HaPanEU): A Netherlands nationwide analysis

Florence Em de Rijk, Marinus A Kempeneers, Marco J Bruno, Marc Gh Besselink, Harry van Goor, Marja A Boermeester, Erwin Jm van Geenen, Jeanin E van Hooft, Hjalmar C van Santvoort, Robert C Verdonk, Dutch Pancreatitis Study Group, Florence Em de Rijk, Marinus A Kempeneers, Marco J Bruno, Marc Gh Besselink, Harry van Goor, Marja A Boermeester, Erwin Jm van Geenen, Jeanin E van Hooft, Hjalmar C van Santvoort, Robert C Verdonk, Dutch Pancreatitis Study Group

Abstract

Background and objective: The 2016, United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) provided evidence-based recommendations for the management of chronic pancreatitis and allowed for the objective evaluation of the quality of care in several domains of disease management through assessment of guideline adherence. Therefore, the aim of this study is to evaluate the current level and the variety of care for chronic pancreatitis patients in the Netherlands using the HaPanEU guidelines as a reference standard. The majority of these patients were diagnosed before the publication of these guidelines. Therefore, in most patients, the results of the present study with respect to those recommendations regarding the diagnostic process of chronic pancreatitis represent guideline correspondence and not adherence.

Methods: A subgroup of patients from the Dutch nationwide chronic pancreatitis registry (CARE) was included in a retrospective cross-sectional observational cohort study. A total of 39 recommendations concerning the non-invasive management of chronic pancreatitis were appointed as quality indicators (QIs). Per patient, the number of relevant QIs was determined and guideline adherence was assessed. Data were analyzed to identify factors associated with guideline adherence.

Results: Overall, 97 patients with chronic pancreatitis from 11 hospitals were included. Per patient, a mean number of 26 relevant QIs was applicable, with an average adherence rate of 53%. In 45% of the patients, guideline adherence was less than 50%. The majority of suboptimal managed QIs concerned the management of chronic pancreatitis complications. Guideline adherence was not associated with hospital type, sex, age or etiology of pancreatitis.

Conclusion: In the Netherlands, adherence to the HaPanEU recommendations for the management of chronic pancreatitis is moderate to low for all non-invasive domains, which may indicate suboptimal care for these patients. Closer guideline adherence could improve the level of care and the clinical outcomes of these patients. A nationwide approach to increase awareness of the key guideline recommendations among clinicians and patients is needed.

Keywords: Chronic pancreatitis; HaPanEU guidelines; PERT; osteopenia; pain; pancreatic exocrine insufficiency; pancreatogenic diabetes; quality of life; therapy.

Figures

Figure 1.
Figure 1.
Flow chart of patient inclusion for this study. CARE: Dutch chronic pancreatitis registry.
Figure 2.
Figure 2.
Guideline adherence in the overall non-invasive management of CP. Values are means (%) ± standard deviation. Mean adherence rate of 52.7 ± 12.6 in 96 patients.

References

    1. Yadav D, Slivka A. Managing chronic pancreatitis: the view from medical pancreatology. Am J Gastroenterol 2018; 113: 1108–1110.
    1. Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology 2016; 16: 218–224.
    1. Bang UC, Benfield T, Hyldstrup L, et al. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. Gastroenterology 2014; 146: 989–994.e1.
    1. Pezzilli R, Bini L, Fantini L, et al. Quality of life in chronic pancreatitis. World J Gastroenterol 2006; 12: 6249–6251.
    1. Friess H, Loehr M, Riemann JF, et al. English language version of the S3-consensus guidelines on chronic pancreatitis: definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis. Z Gastroenterol 2015; 53: 1447–1495.
    1. Amann ST, Yadav D, Barmada MM, et al. Physical and mental quality of life in chronic pancreatitis. Pancreas 2013; 42: 293–300.
    1. Bruno MJ. Chronic pancreatitis. Gastrointest Endosc Clin N Am 2005; 15: 55–62.
    1. Mokrowiecka A, Pinkowski D, Malecka-Panas E, et al. Clinical, emotional and social factors associated with quality of life in chronic pancreatitis. Pancreatology 2010; 10: 39–46.
    1. Pezzilli R, Morselli-Labate AM, Frulloni L, et al. The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis 2006; 38: 109–115.
    1. Pezzilli R, Morselli-Labate AM, Fantini L, et al. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis 2007; 39: 1077–1086.
    1. Machicado JD, Amann ST, Anderson MA, et al. Quality of life in chronic pancreatitis is determined by constant pain, disability/unemployment, current smoking, and associated co-morbidities. Am J Gastroenterol 2017; 112: 633–642.
    1. Kempeneers MA, Besselink MG, Issa Y, et al. Multidisciplinaire behandeling van chronische pancreatitis [Multidisciplinary treatment of chronic pancreatitis: an overview of current step-up approach and new options]. Ned Tijdschr Geneeskd. 2017;161:D1454.
    1. Pham A, Forsmark C. Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Research 2018; 7: 607.
    1. Robinson SM, Rasch S, Beer S, et al. Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis. Sci Rep 2019; 9: 1–8.
    1. Parhiala M, Sand J, Laukkarinen J. A population-based study of chronic pancreatitis in Finland: effects on quality of life. Pancreatology 2020; 20: 338–346.
    1. Issa Y, van Santvoort HC, Fockens P, et al. Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study. Hpb 2017; 19: 978–985.
    1. Sikkens ECM, Cahen DL, van Eijck C, et al. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. Pancreatology 2012; 12: 71–73.
    1. Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United Eur Gastroenterol J 2017; 5: 153–199.
    1. Ahmed Ali U, Issa Y, Van Goor H, et al. Dutch chronic pancreatitis registry (CARE): design and rationale of a nationwide prospective evaluation and follow-up. Pancreatology 2015; 15: 46–52.
    1. Kavanagh BP. The GRADE system for rating clinical guidelines. PLoS Med 2009; 6: e1000094.
    1. Lévy P, Domínguez-Muñoz E, Imrie C, et al. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United Eur Gastroenterol J 2014; 2: 345–354.
    1. Wassef W, Bova C, Barton B, et al. Pancreatitis quality of life instrument: development of a new instrument. SAGE Open Med 2014; 2: 205031211452085.
    1. Keikes L, van Oijen MGH, Lemmens VEPP, et al. Evaluation of guideline adherence in colorectal cancer treatment in the Netherlands: a survey among medical oncologists by the Dutch colorectal cancer group. Clin Colorectal Cancer 2018; 17: 58–64.
    1. Van Rijssen LB, Van Der Geest LGM, Bollen TL, et al. National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma. Pancreatology 2016; 16: 133–137.
    1. Dominguez-Munoz JE, Drewes AM, Lindkvist B, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology 2018; 18: 847–854.
    1. Sikkens ECM, Cahen DL, Koch AD, et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology 2013; 13: 238–242.
    1. Liang L, Bernhardsson S, Vernooij RWM, et al. Use of theory to plan or evaluate guideline implementation among physicians: a scoping review. Implement Sci 2017; 12: 1–12.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться